Orthopaedics market in Asia starts to take off
This article was originally published in Clinica
The Asian orthopaedics market is set to significantly outperform the US and European markets over the next few years despite cutbacks in equipment purchasing caused by economic uncertainty, says a new report from market analysts Datamonitor. Although the Asian knee implant market, for example, will decline in value this year, by 2002 it will have increased by 48% to reach $75 million, according to the report.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.